ARAY
ACCURAY INC
NASDAQ · Healthcare · Medical - Devices · US
$0.15
−6.81%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.16
From 52W high−91.41%
Volume3.31M
Market cap$17.35M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 19, 2026
Open
$0.16
From 52W high
−91.41%
Volume
3.31M
Market cap
$17.35M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−25.1x
P/E (TTM)
—
RSI (14)
27.6
MomentumView details →
1D Return
−6.81%
YTD Return
−82.60%
SummaryUpdated Jun 1, 2026
Accuray Incorporated (NASDAQ:ARAY) is a medical device company founded in 1990 and headquartered in Madison, Wisconsin. The company went public in February 2007 and specializes in designing, developing, manufacturing, and selling advanced radiosurgery and radiation therapy systems for cancer treatment. Accuray serves hospitals and treatment facilities globally, with operations spanning the United States, Canada, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific region. The company has established itself as a key player in the precision radiation therapy market, with over 1,000 systems installed worldwide.
Similar companies
Latest newsMore news →
ACCURAY INC reported that Class II director Mika Nishimura departed following the expiration of her term.6d agoAccuray stockholders approved all proposals presented at the company’s special meeting, enabling the company to complete previously announced transactions with TCW Asset Management Company.13d ago